Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Heirman

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Cancer Research|February 17, 2012
Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapySandra Van Lint, Cleo Goyvaerts, Sarah Maenhout, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2020
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastasesYanina Jansen, Vibeke Kruse, Jurgen Corthals, et al.
Scientific Reports|March 3, 2016
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursLukasz Bialkowski, Alexia van Weijnen, Kevin Van der Jeught, et al.
Journal of Leukocyte Biology|March 24, 2011
The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responsesBrenda De Keersmaecker, Carlo Heirman, Jurgen Corthals, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
An alternative pathway of NF-kappaB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IkappaBalphaFabrice Moore, Sofia Buonocore, Ezra Aksoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patientsAude Bonehill, An M T Van Nuffel, Jurgen Corthals, et al.
Cancer Research|March 2, 2012
Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapyPerpetua U Emeagi, Sandra Van Lint, Cleo Goyvaerts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocolsMelissa Dullaers, Karine Breckpot, Sonja Van Meirvenne, et al.
Diabetologia|May 24, 2018
Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisationWillem Staels, Yannick Verdonck, Yves Heremans, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 29, 2012
Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patientsAn M T Van Nuffel, Daphné Benteyn, Sofie Wilgenhof, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Cancer Research|February 17, 2012
Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapySandra Van Lint, Cleo Goyvaerts, Sarah Maenhout, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2020
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastasesYanina Jansen, Vibeke Kruse, Jurgen Corthals, et al.
Scientific Reports|March 3, 2016
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursLukasz Bialkowski, Alexia van Weijnen, Kevin Van der Jeught, et al.
Journal of Leukocyte Biology|March 24, 2011
The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responsesBrenda De Keersmaecker, Carlo Heirman, Jurgen Corthals, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
An alternative pathway of NF-kappaB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IkappaBalphaFabrice Moore, Sofia Buonocore, Ezra Aksoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patientsAude Bonehill, An M T Van Nuffel, Jurgen Corthals, et al.
Cancer Research|March 2, 2012
Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapyPerpetua U Emeagi, Sandra Van Lint, Cleo Goyvaerts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocolsMelissa Dullaers, Karine Breckpot, Sonja Van Meirvenne, et al.
Diabetologia|May 24, 2018
Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisationWillem Staels, Yannick Verdonck, Yves Heremans, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 29, 2012
Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patientsAn M T Van Nuffel, Daphné Benteyn, Sofie Wilgenhof, et al.
Pageof 8